Natixis Advisors
ASTH icon

Natixis Advisors’s Astrana Health ASTH Stock Holding History

Natixis Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
38,127
+634
+2% +$22.8K ﹤0.01% 1282
2026
Q1 		$919K Sell
37,493
-854
-2% -$20.2K ﹤0.01% 1388
2025
Q4 		$951K Sell
38,347
-620
-2% -$16.5K ﹤0.01% 1275
2025
Q3 		$1.1M Sell
38,967
-200
-0.5% -$5.42K ﹤0.01% 1290
2025
Q2 		$974K Buy
39,167
+11,545
+42% +$325K ﹤0.01% 1303
2025
Q1 		$857K Buy
27,622
+3,462
+14% +$115K ﹤0.01% 1313
2024
Q4 		$762K Sell
24,160
-3,820
-14% -$181K ﹤0.01% 1385
2024
Q3 		$1.62M Buy
27,980
+404
+1% +$19.9K ﹤0.01% 1152
2024
Q2 		$1.12M Sell
27,576
-216
-0.8% -$8.57K ﹤0.01% 1218
2024
Q1 		$1.17M Buy
27,792
+2,131
+8% +$83.1K ﹤0.01% 1171
2023
Q4 		$982K Buy
+25,661
New +$855K ﹤0.01% 1211

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Natixis Advisors's ASTH Position: Q2 2026 in Review

Natixis Advisors increased its Astrana Health (ASTH) stake by 1.7% in Q2 2026, buying an estimated $22.8K and bringing the position to 38,127 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1282.

Natixis Advisors first reported a position in ASTH in Q4 2023 and has held it in 11 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Natixis Advisors held 38,127 shares of Astrana Health worth $1.77M as of Q2 2026.
  • Natixis Advisors bought 634 Astrana Health shares in Q2 2026, an estimated $22.8K.
  • Astrana Health made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1282 holding.
  • Natixis Advisors first reported a position in Astrana Health in Q4 2023 and has held it in 11 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.